25B-NBF
Chemical compound
From Wikipedia, the free encyclopedia
25B-NBF (2C-B-NBF, NBF-2C-B) is a derivative of the phenethylamine hallucinogen 2C-B, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1][2]
Other names2C-B-NBF; NBF-2C-B
ATC code
- (HCl): None
Legal status
- DE: NpSG (Industrial and scientific use only)
- UK: Under Psychoactive Substances Act
CAS Number
- (HCl): 1391487-99-2
| |
| Clinical data | |
|---|---|
| Other names | 2C-B-NBF; NBF-2C-B |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| CompTox Dashboard (EPA) |
|
| Chemical and physical data | |
| 3D model (JSmol) |
|
| |
| |
Society and culture
Legal status
Sweden
The Riksdag added 25B-NBF to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 26, 2016, published by Medical Products Agency (MPA) in regulation HSLF-FS 2015:35 listed as 25B-NBF, and 2-(4-bromo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin.[3]
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[4]